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Submitted Sep 20, 2012; accepted Nov 14, 2012.INVITED COMMENTARYAhmed M. Abou-Zamzam Jr, MD, Loma Linda, CalifMcPhee et al1 have reviewed the Project of Ex-Vivo graft
Engineering via Transfection III (PREVENT III) database of
patients undergoing lower extremity vein bypass for critical limb
ischemia (CLI) and evaluated the rates and predictors of 30-day
readmissions. In the nearly 1400 patients, there was an overall
30-day readmission rate of 24%. The factors predictive of read-
mission included female gender, current smoking, dialysis-
dependence, in-hospital graft-related events, and tissue loss as an
indication for surgery. A simple scoring system using these values
had a moderate correlation with the readmission rates.
The PREVENT III data have given interesting benchmarks
for outcomes after vein bypass for CLI such as patency rates and
wound complications.2 In the current report, the most common
reason for readmission was wound infection (40%). However,
nearly 21% of readmissions were for an “additional procedure
in the index limb.” This clouds the issue of whether these read-
missions were planned or unplanned. In many instances, patients
with CLI require multiple interventions for limb salvage. Thus,
patients who require minor foot amputations as a routine part
of their treatment were identiﬁed as readmissions. However,
the PREVENT III database did not discriminate between
planned and unplanned readmissions. To overcome this, the
authors point to a report of their own experience with >1500
bypasses with a 23% readmission rate in which only 3% of read-
missions were planned.3 Although this may be true at their insti-
tution, extrapolation to the PREVENT III trial may not be
reliable.
Only a prospective study with unplanned readmission as
a primary end point would solve this issue, and more data, such
as in the current report, are necessary to lay the groundwork for
meaningful outcomes benchmarks in CLI. The current report
demonstrates that although the predictors of readmission cannot
be modiﬁed, they can be identiﬁed at the time of discharge.
This may help target patients who need special postdischarge
care or delayed discharge to prevent readmission. In fast-track
colon surgery, a simple measure, such as extending the length
of stay by 1 day, reduced readmission rates in half.4 Perhapsfurther studies in CLI will identify similar measures to avoid
readmissions.
The relevance of this current report rests on the very real
impact that value-based purchasing is having on hospitals and
providers. Identifying readmissions #30 days as a measure of
quality of care is currently being done for acute myocardial infarc-
tion, heart failure, and pneumonia. Centers for Medicare and
Medicaid Services has proposed “hospital-wide all-cause un-
planned readmission” as a measure to be followed beginning in
ﬁscal year 2015.5 To have relevant core measures, the anticipated
outcomes must be known to identify provider outliers. Perhaps
patients with CLI and other conditions requiring multiple planned
interventions should be excluded from certain metrics. In view of
value-based purchasing, having good data on a wide scale will help
protect our best-intentioned treatments from unnecessary punitive
measures when providing care to patients with CLI.REFERENCES
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